This breakthrough marks the first molecularly-based test that can accurately diagnose mesothelioma from other types of cancers found in the lung.
MicroRNAs are recently-discovered RNAs that consist of a chain of [...]" (2008-12-31)
mercredi 31 décembre 2008
Mesothelioma Treatment Gets Boost with New Diagnostic Test
"Israeli-based MicroRNA company, Rosetta Genomics, has made a giant leap in cancer diagnosis by announcing the commercial availability of its third diagnostic test, miRview (TM) meso.
This breakthrough marks the first molecularly-based test that can accurately diagnose mesothelioma from other types of cancers found in the lung.
MicroRNAs are recently-discovered RNAs that consist of a chain of [...]" (2008-12-31)
Read more...
This breakthrough marks the first molecularly-based test that can accurately diagnose mesothelioma from other types of cancers found in the lung.
MicroRNAs are recently-discovered RNAs that consist of a chain of [...]" (2008-12-31)
